Cervical Cancer Awareness Month
With this first issue of 2021, you may notice something different on the cover and on the banner of our website. This special design features a teal ribbon wrap and related content for cervical cancer content.
As women’s health care providers, you likely know that January is Cervical Cancer Awareness month. The teal ribbon is its awareness symbol. To complement the print issue, key elements on our website will turn teal for the entire month of January and we will have related articles and interviews on the topic of cervical cancer. This is a first for us and we would like to hear your feedback on it.
Under the astute guidance of Editor-in-Chief Catherine Y. Spong, MD, we also are launching a new feature in this issue called Curbside Consults that engages practitioners outside of ob/gyn with expertise in health issues that may affect pregnant women. Take a dive into dental issues in pregnancy with 'Dental dilemmas in pregnancy.'
The other features in this issue focus on obstetrics, from the cover story on one method to address recurrent pregnancy loss by Nisse Clark, MD, MPH, to the article on diagnosis and management of syphilis in pregnancy by Emily Adhikari, MD, who reminds us that there are other infectious pathogens affecting our patients as we all work to get to the end of the COVID-19 pandemic.
We encourage your feedback. Please connect with us at COGeditorial@mmhgroup.com. Best wishes for a safe, healthy, and happy new year.
__
Mike Hennessy Sr.
Chairman and Founder, MJH Life Sciences
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
